Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Research & Development: 2022-2024

Historic Research & Development for Molecular Partners Ag (MOLN) over the last 3 years, with Dec 2024 value amounting to $55.2 million.

  • Molecular Partners Ag's Research & Development rose 16.98% to -$10,411 in Q3 2025 from the same period last year, while for Sep 2025 it was $55.5 million, marking a year-over-year increase of 0.90%. This contributed to the annual value of $55.2 million for FY2024, which is 1.71% up from last year.
  • Per Molecular Partners Ag's latest filing, its Research & Development stood at $55.2 million for FY2024, which was up 1.71% from $54.3 million recorded in FY2023.
  • In the past 5 years, Molecular Partners Ag's Research & Development ranged from a high of $55.2 million in FY2024 and a low of $52.7 million during FY2022.
  • Over the past 3 years, Molecular Partners Ag's median Research & Development value was $54.3 million (recorded in 2023), while the average stood at $54.1 million.
  • Data for Molecular Partners Ag's Research & Development shows a peak YoY climbed of 3.11% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Molecular Partners Ag's Research & Development stood at $52.7 million in 2022, then climbed by 3.11% to $54.3 million in 2023, then grew by 1.71% to $55.2 million in 2024.